By
admin
#Acquisitions, #Acquisitions/Mergers/Takeovers, #apparatus, #article_normal, #BIO, #Bio-Rad Laboratories Inc. Cl A, #Bio-Rad Laboratories Inc. Cl B, #BIO.B, #Biology, #BioRad, #Biotech, #Biotechnology, #C&E Industry News Filter, #Content Types, #Corporate, #Corporate Actions, #Corporate/Industrial News, #diagnostic, #Diagnostic/Therapeutic Devices, #Factiva Filters, #general news, #Germanbased, #Healthcare, #Healthcare/Life Sciences, #humanities, #industrial news, #latest, #life sciences, #market, #medical devices, #Medical Devices/Apparatus, #medical diagnostic equipment, #Medical Diagnostic Equipment/Supplies, #medical equipment, #Medical Equipment/Supplies, #medicaldiagnostic, #Mergers, #Ownership Changes, #Political, #Political/General News, #QGEN, #Qiagen, #Qiagen N.V., #sciences, #Sciences/Humanities, #supplies, #takeovers, #therapeutic devices, #tieup, #weighing, #XE:QIA
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more — and there may not be one.
